Amanta Healthcare Share Price Gains Over 7% Post Q2 FY27 Earnings Results: Total Income Up 18.2% YoY

On November 3, 2026, Amanta Healthcare Limited reported unaudited results for the quarter ended September 30, 2026, showing notable growth in both revenue and profit compared with the same period last year and the preceding quarter, as per the exchange filings. 

Amanta Healthcare Q2 FY27 Earnings Results  

Amanta Healthcare Limited's total income up 18.2% YoY to ₹83.89 crore in the September 2026 quarter from ₹70.96 crore a year ago, and up 20.8% QoQ from ₹69.45 crore in the June 2026 quarter. 

Net profit (PAT) up 302.6% YoY to ₹4.86 crore in the September 2026 quarter from ₹1.21 crore a year ago, and up 46.8% QoQ from ₹3.31 crore in the June 2026 quarter. 

Half‑Yearly Overview  

For the six months ended September 30, 2026, total income was ₹153.33 crore, up 11.7 % YoY from ₹137.23 crore. Net profit (PAT) for the half year increased to ₹8.17 crore, up 73.3 % YoY from ₹4.71 crore. 

Amanta Healthcare Operational Highlights 

EBITDA for Q2 FY27 was ₹17.95 crore, up 21.9 % YoY from ₹14.72 crore, giving an EBITDA margin of 21.6 % versus 20.8 % previously. Other expenses fell 4.5 % YoY, supporting the margin expansion. H1 FY27 EBITDA stood at ₹33.13 crore, an 8.4 % YoY rise. Finance costs increased 13.4 % YoY to ₹5.84 crore. 

Read More: Route Mobile Share Price in Focus; Launches AI-Powered Voice Fraud Protection Solution 365callguard! 

Capacity Expansion Initiatives 

SteriPort Line 3 was commissioned in the first week of September 2026 at the Kheda facility, raising SteriPort capacity by 75 % from 6.6 crore to 11.6 crore bottles and is expected to add roughly ₹60 crore of revenue in FY27.  

The SVP expansion will lift capacity from 20.9 crore to 31.7 crore units, targeted for Q1 FY28, adding inhalation, ophthalmic and diluent output.  

A 10.8 MW captive solar plant, operational since the end of Q1 FY27, is projected to save about ₹9 crore annually. 

Amanta Healthcare Share Price Performance  

As of November 04, 2026, at 12:21 PM, Amanta Healthcare share price on NSE was trading at ₹185.48 up by 7.54% from the previous closing price. 

Conclusion 

The September 2026 quarter delivered strong revenue and profit growth, supported by higher pricing, new product sales and expanding manufacturing capacity for Amanta Healthcare. Operational metrics such as EBITDA margin improved, while investments in capacity and a captive solar plant are set to contribute additional cost efficiencies. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.